SCHEMBL1753897

SCHEMBL1753897

CC(C)(C)OC(=O)Nc1ccccc1NC(=O)c1ccc(C(C)(C(=O)Nc2ccccc2)C(=O)Nc2ccccc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 8/20 0.68
NAMPT P43490 1/20 0.51
RXFP1 Q9HBX9 1/20 0.47
HDAC3 O15379 3/20 0.46
HDAC2 Q92769 2/20 0.46
NCOR2 Q9Y618 2/20 0.46
HDAC4 P56524 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45
LMNA P02545 1/20 0.45
F10 P00742 1/20 0.45
NPC1 O15118 1/20 0.44
ALDH1A1 P00352 1/20 0.44
GLA P06280 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1753684 0.88 HDAC1 (0.65) HDAC1NAMPTRXFP1HDAC3HDAC2
SCHEMBL2106401 0.86 HDAC1 (0.76) HDAC1HDAC3HDAC2NCOR2HDAC4
SCHEMBL1753893 0.85 MEN1 (0.50) HDAC1NAMPTRXFP1F10NPC1
SCHEMBL2829176 0.84 POLB (0.56) HDAC1NAMPTRXFP1HDAC3HDAC2
SCHEMBL3662421 0.83 F10 (0.53) HDAC1NAMPTF10NPC1ALDH1A1
SCHEMBL248347 0.82 CACNA1B (0.57) HDAC1NAMPTRXFP1HDAC3HDAC2
SCHEMBL1754084 0.81 HDAC1 (1.00) HDAC1HDAC3HDAC2NCOR2HDAC4
SCHEMBL1753682 0.81 HDAC1 (0.63) HDAC1NAMPTRXFP1HDAC3HDAC2
SCHEMBL13949629 0.80 MEN1 (0.54) HDAC1NAMPTRXFP1HDAC2F10
SCHEMBL1066788 0.80 F10 (0.53) HDAC1NAMPTRXFP1F10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158825-B2 Modified malonate derivatives MERCK SHARP & DOHME CORP. (US) 2012-04-17 US disclosed
US-20100160327-A1 Modified Malonate Derivatives MERCK SHARP & DOHME LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160327-A1 Modified Malonate Derivatives ME2, ME3, ME1 HDAC1 6/4885NAMPT 737/4885RXFP1 4561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.